{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:30:12Z","timestamp":1793608212720,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clml.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:54:31Z","timestamp":1775667271000},"page":"e820-e828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma"],"prefix":"10.1016","volume":"26","author":[{"given":"Margherita","family":"Scopetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Entizne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lazzaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo C.","family":"Da Vi\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-9095","authenticated-orcid":false,"given":"Marta","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Bolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clml.2026.04.003_bib0001","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"issue":"7381","key":"10.1016\/j.clml.2026.04.003_bib0002","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"issue":"7239","key":"10.1016\/j.clml.2026.04.003_bib0003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.clml.2026.04.003_bib0004","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.clml.2026.04.003_bib0005","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"New Engl J Med"},{"issue":"26","key":"10.1016\/j.clml.2026.04.003_bib0006","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"New Engl J Med"},{"issue":"8","key":"10.1016\/j.clml.2026.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Rep"},{"issue":"7913","key":"10.1016\/j.clml.2026.04.003_bib0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","article-title":"Clonal dynamics of haematopoiesis across the human lifespan","volume":"606","author":"Mitchell","year":"2022","journal-title":"Nature"},{"issue":"7913","key":"10.1016\/j.clml.2026.04.003_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","article-title":"The longitudinal dynamics and natural history of clonal haematopoiesis","volume":"606","author":"Fabre","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.clml.2026.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41588-024-01755-1","article-title":"Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis","volume":"56","author":"Bernstein","year":"2024","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201544","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"218","author":"Trowbridge","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.clml.2026.04.003_bib0012","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exphem.2019.12.005","article-title":"Environmental influences on clonal hematopoiesis","volume":"83","author":"King","year":"2020","journal-title":"Exp Hematol"},{"issue":"6568","key":"10.1016\/j.clml.2026.04.003_bib0013","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.aba9304","article-title":"Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis","volume":"374","author":"Avagyan","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.clml.2026.04.003_bib0014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","article-title":"Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease","volume":"17","author":"Jaiswal","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clml.2026.04.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104187","article-title":"Clonal hematopoiesis and inflammation: a review of mechanisms and clinical implications","volume":"192","author":"Nathan","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.04.003_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clml.2026.04.003_bib0017","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"New Engl J Med"},{"issue":"13","key":"10.1016\/j.clml.2026.04.003_bib0018","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra2412716","article-title":"Monoclonal gammopathy of undetermined significance","volume":"393","author":"Rajkumar","year":"2025","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clml.2026.04.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-026-01119-0","article-title":"Diagnosis, risk stratification and management of smouldering multiple myeloma","author":"Zanwar","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"10.1016\/j.clml.2026.04.003_bib0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"Das","year":"2016","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.clml.2026.04.003_bib0021","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0022","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0023","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/leu.2015.17","article-title":"Quantifying ultra-rare pre-leukemic clones via targeted error-corrected sequencing","volume":"29","author":"Young","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2026.04.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clml.2026.04.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-025-00936-y","article-title":"Inflammageing and clonal haematopoiesis interplay and their impact on human disease","author":"Hajishengallis","year":"2026","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0026","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood.2023019964","article-title":"The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia","volume":"143","author":"Fabre","year":"2024","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2026.04.003_bib0027","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.clml.2026.04.003_bib0028","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","article-title":"Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking","volume":"34","author":"Dawoud","year":"2020","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.clml.2026.04.003_bib0029","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/s41588-025-02296-x","article-title":"Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis","volume":"57","author":"McLoughlin","year":"2025","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.seminhematol.2024.01.013","article-title":"TET2 mutation as prototypic clonal hematopoiesis lesion","volume":"61","author":"Guarnera","year":"2024","journal-title":"Sem Hematol"},{"issue":"19","key":"10.1016\/j.clml.2026.04.003_bib0031","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/bloodadvances.2024012929","article-title":"Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes","volume":"8","author":"Nead","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.clml.2026.04.003_bib0032","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0033","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","article-title":"Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.clml.2026.04.003_bib0034","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1182\/bloodadvances.2024013228","article-title":"Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis","volume":"8","author":"Singh","year":"2024","journal-title":"Blood Adv"},{"issue":"19","key":"10.1016\/j.clml.2026.04.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180065","article-title":"Clonal hematopoiesis and hematological malignancy","volume":"134","author":"Dunn","year":"2024","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.clml.2026.04.003_bib0036","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2643-3230.BCD-24-0355","article-title":"Clinical significance of TP53-mutant clonal hematopoiesis across diseases","volume":"6","author":"Usui","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"9","key":"10.1016\/j.clml.2026.04.003_bib0037","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41588-023-01472-1","article-title":"Multiparameter prediction of myeloid neoplasia risk","volume":"55","author":"Gu","year":"2023","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.clml.2026.04.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"issue":"19","key":"10.1016\/j.clml.2026.04.003_bib0039","first-page":"2359","article-title":"Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures","volume":"141","author":"Diamond","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(16)30627-1","article-title":"Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study","volume":"18","author":"Gillis","year":"2017","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clml.2026.04.003_bib0041","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/bloodadvances.2019001157","article-title":"Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation","volume":"4","author":"Soerensen","year":"2020","journal-title":"Blood Adv"},{"issue":"21","key":"10.1016\/j.clml.2026.04.003_bib0042","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1182\/bloodadvances.2021006498","article-title":"MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort","volume":"6","author":"Da Vi\u00e0","year":"2022","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0043","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41408-022-00706-5","article-title":"Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms","volume":"12","author":"Gagnon","year":"2022","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.clml.2026.04.003_bib0044","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.seminoncol.2022.11.001","article-title":"Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias","volume":"49","author":"Testa","year":"2022","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.clml.2026.04.003_bib0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.2024025738","article-title":"Inflammatory Waldenstr\u00f6m macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort","volume":"145","author":"Debureaux","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.04.003_bib0046","article-title":"The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia","author":"Al-Sawaf","year":"2025","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.clml.2026.04.003_bib0047","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/bloodadvances.2021006652","article-title":"Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma","volume":"6","author":"Peres","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.clml.2026.04.003_bib0048","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.2024026236","article-title":"Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes","volume":"146","author":"Lionetti","year":"2025","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.clml.2026.04.003_bib0049","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/2767-9764.CRC-23-0093","article-title":"Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma","volume":"3","author":"Mouhieddine","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"3","key":"10.1016\/j.clml.2026.04.003_bib0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/2643-3230.BCD-24-0274","article-title":"Dynamics of mutant hematopoietic progenitor cells are not associated with clinical outcomes in multiple myeloma","volume":"6","author":"Guerrero","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0051","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41375-021-01320-3","article-title":"Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length","volume":"36","author":"Boyle","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79748-7","article-title":"Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis","volume":"14","author":"Gelli","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.clml.2026.04.003_bib0053","first-page":"1","article-title":"Clonal independence of CHIP-associated mutations in multiple myeloma","author":"Wobst","year":"2026","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0054","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.clml.2026.04.003_bib0055","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41375-018-0208-8","article-title":"Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation","volume":"32","author":"Chitre","year":"2018","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.clml.2026.04.003_bib0056","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1002\/ajh.26125","article-title":"Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy","volume":"96","author":"Wudhikarn","year":"2021","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0057","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.celrep.2019.04.064","article-title":"Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation","volume":"27","author":"Ortmann","year":"2019","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.clml.2026.04.003_bib0058","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41375-025-02707-2","article-title":"Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma","volume":"39","author":"Cooperrider","year":"2025","journal-title":"Leukemia"},{"issue":"S2","key":"10.1016\/j.clml.2026.04.003_bib0059","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.HS9.0000936220.68605.8b","article-title":"P23 Emagine\/Cartitude-6: a randomized phase 3 study of DVRD followed by ciltacabtagene autoleucel versus DVRD followed by autologous stem cell transplant in transplant-eligible patients with newly diagnosed multiple myeloma","volume":"7","author":"Broijl","year":"2023","journal-title":"HemaSphere"},{"issue":"5","key":"10.1016\/j.clml.2026.04.003_bib0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa2505133","article-title":"Measurable residual disease-guided therapy in newly diagnosed myeloma","volume":"393","author":"Perrot","year":"2025","journal-title":"N Engl J Med"},{"issue":"6327","key":"10.1016\/j.clml.2026.04.003_bib0061","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65803-y","article-title":"Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia","volume":"16","author":"Prummel","year":"2025","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.clml.2026.04.003_bib0063","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184285","article-title":"Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment","volume":"136","author":"Chen","year":"2026","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0064","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"Bolli","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0065","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41467-021-22140-0","article-title":"Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities","volume":"12","author":"Oben","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.clml.2026.04.003_bib0066","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2024025643","article-title":"Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma","author":"Da Vi\u00e1","year":"2025","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2026.04.003_bib0067","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41577-024-01003-x","article-title":"Bone marrow inflammation in haematological malignancies","volume":"24","author":"de Jong","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"20","key":"10.1016\/j.clml.2026.04.003_bib0068","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2026.04.003_bib0069","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3390\/cells13080657","article-title":"Single-cell DNA sequencing reveals an evolutionary pattern of CHIP in transplant eligible multiple myeloma patients","volume":"13","author":"Borsi","year":"2024","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.clml.2026.04.003_bib0070","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/bloodadvances.2022007497","article-title":"Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study","volume":"7","author":"Hazenberg","year":"2023","journal-title":"Blood Adv"},{"issue":"16","key":"10.1016\/j.clml.2026.04.003_bib0071","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood.2021014956","article-title":"Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms","volume":"140","author":"Sperling","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2026.04.003_bib0072","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.jtct.2023.06.015","article-title":"Characteristics and outcomes of patients with multiple myeloma who developed therapy-related acute myeloid leukemia and myelodysplastic syndrome after autologous cell transplantation","volume":"30","author":"Yalniz","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.clml.2026.04.003_bib0073","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2303379","article-title":"Cilta-cel or standard care in lenalidomide-refractory multiple myeloma","volume":"389","author":"San-Miguel","year":"2023","journal-title":"N Engl J Med"},{"issue":"10297","key":"10.1016\/j.clml.2026.04.003_bib0074","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.clml.2026.04.003_bib0075","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1158\/1078-0432.CCR-25-1587","article-title":"Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy","volume":"31","author":"Avigan","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.clml.2026.04.003_bib0076","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.2019003382","article-title":"Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma","volume":"135","author":"Maia","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2026.04.003_bib0077","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.3390\/cimb46080484","article-title":"Rising prevalence of low-frequency PPM1D gene mutations after second HDCT in multiple myeloma","volume":"46","author":"Seipel","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"10.1016\/j.clml.2026.04.003_bib0078","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bjh.18716","article-title":"Clonal haematopoiesis of indeterminate potential predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma","volume":"201","author":"Li","year":"2023","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.clml.2026.04.003_bib0079","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.3324\/haematol.2023.282992","article-title":"Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"issue":"2, Supplement","key":"10.1016\/j.clml.2026.04.003_bib0080","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1016\/j.jtct.2025.01.359","article-title":"Impact of clonal hematopoiesis of indeterminate potential (CHIP) on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy","volume":"31","author":"Carlson","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.clml.2026.04.003_bib0081","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/bloodadvances.2025015981","article-title":"Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma","volume":"9","author":"Gustine","year":"2025","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"10.1016\/j.clml.2026.04.003_bib0082","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood-2025-930","article-title":"Beyond chip: CCRS predicts prolonged cytopenias and inferior survival following anti-BCMA CAR-T in multiple myeloma","volume":"146","author":"Xie","year":"2025","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clml.2026.04.003_bib0083","doi-asserted-by":"crossref","first-page":"927.e1","DOI":"10.1016\/j.jtct.2024.06.008","article-title":"Clonal hematopoiesis is associated with severe cytokine release syndrome in patients treated with chimeric antigen receptor T-cell (CART) therapy","volume":"30","author":"Goldsmith","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.clml.2026.04.003_bib0084","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jamacardio.2023.4105","article-title":"Clonal hematopoiesis and cardiovascular disease in patients with multiple myeloma undergoing hematopoietic cell transplant","volume":"9","author":"Rhee","year":"2024","journal-title":"JAMA Cardiol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:16:11Z","timestamp":1793607371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2152265026001035"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.04.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}